查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466640

抗菌药物抗药性监测市场：按组件、最终用户划分 - 2024-2030 年全球预测

Antimicrobial Resistance Surveillance Market by Component (Diagnostic Kits, Diagnostic Systems, Services), End-User (Hospitals, Research & Academic Institutes) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年抗菌药物抗药性监测市场规模为56亿美元，预计2024年将达59.6亿美元，2030年将达到87.1亿美元，复合年增长率为6.49%。

抗菌药物抗药性监测市场包括监测、分析和控制对抗生素、抗病毒药物、抗真菌药物和其他抗菌药物产生抗药性的微生物传播的产品。抗菌药物抗药性监测的主要用途是提供有关各种环境中抗药性病原体流行情况的信息，例如医院、社区健康中心、食品生产设施、畜牧业、水处理厂和环境样本。世界各地的多重抗药性细菌数量不断增加，需要不断监测，以确保现有治疗方法得到适当调整。分子诊断技术的进步使得能够及早检测和鑑定抗生素抗药性菌株。此外，医疗保健专业人员对抗生素管理计划的认识不断提高也鼓励审慎处方。儘管存在成长前景，但一些挑战阻碍了抗菌药物抗药性监测市场的进步。由于基础设施和资金不足，低收入和中等收入国家的监测能力有限。世界各地采用的调查方法存在差异，阻碍了不同地区结果的可比较性。然而，就地检验设备的出现加快了诊断速度，并允许做出个人化的治疗决策。基因组测序技术使我们能够在人群层面上准确追踪抗药性机制和感染动态。除此之外，为了维持业务成长并为全球健康安全做出贡献，相关人员正在寻求改进诊断工具以实现更快的检测，探索非常规治疗方法，并使用预测模型来维持业务成长并为全球健康安全做出贡献。

主要市场统计
基准年[2023] 56亿美元
预测年份 [2024] 59.6亿美元
预测年份 [2030] 87.1亿美元
复合年增长率（%） 6.49%

以相对较低的成本快速检测组件特异性电阻标记的套件发挥重要作用。

抗菌素抗药性 (AMR) 监测市场由各种有助于识别和管理抗药性病原体的组成部分组成。诊断套件对于准确、快速地检测病原菌中的抗菌药物抗药性并及时采取适当的抗生素治疗进行干预至关重要。这些套件采用多种技术来辨识微生物中的抗性基因，包括聚合酵素链锁反应(PCR)、酵素结合免疫吸附检测法(ELISA) 和次世代定序(NGS)。诊断系统包括基于实验室的仪器，可促进 AMR 检测的高通量筛检和进阶资料分析。 AMR 监测服务包括提供快速药敏测试、全基因组定序和生物资讯分析的受託研究机构(CRO) 和实验室。这些服务使医疗保健提供者能够获得尖端技术和专业知识来检测抗药性病原体，而无需投资昂贵的设备或专家。资料管理软体在汇总、分析和解释 AMR 监测过程中产生的大量资讯方面发挥关键作用。

最终用户：医院感染的增加增加了对下一代抗菌素抗药性 (AMR) 监测的需求

医院、研究和学术机构在对抗抗菌素抗药性 (AMR) 的斗争中发挥着重要作用，并需要适合其需求的监测系统。医院将优先考虑快速诊断解决方案，以指南临床医生提供适当的抗生素治疗并防止抗药性感染的传播。研究和学术机构致力于阐明抗菌素抗药性机制、开发新的治疗方法以及促进医疗保健专业人员负责任地使用抗生素。

区域洞察

抗菌素抗药性 (AMR) 正成为美洲和欧洲的主要公共卫生威胁。持续监测抗菌素抗药性对于了解其对医疗保健系统日益增长的影响、指导政策决策以及实施有效策略以降低与抗药性感染相关的风险至关重要。人类医学、兽医实践、农业和食品生产领域抗生素的过度使用和滥用是美洲和欧洲抗菌素抗药性水平上升的主要驱动因素。在美洲和欧洲的已开发国家，抗生素製造商和供应商的行为受到严格的法律规范的约束。由于经济快速成长、医疗保健支出增加以及有利的政府政策等因素，新兴国家在应对抗菌素抗药性方面潜力巨大。印度、中国和巴西等新兴国家正大力投资抗生素抗药性监测研究和开发，并促进官民合作关係关係来解决这个问题。各国政府正为研发 (R&D) 工作提供财政支持，以奖励创新以解决抗菌素抗药性问题。例如，2023年8月，英国政府投入2.1亿英镑的巨额投资，加强全球抗药性细菌监测，这是抗菌素抗药性（AMR）监测的关键方面。然而，加强监测系统、改善法律规范、投资研究和开发新治疗方法对于有效应对此威胁至关重要。

FPNV定位矩阵

FPNV 定位矩阵对于评估抗菌药物抗药性监测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对抗菌药物抗药性监测市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 抗菌药物抗药性监测市场的市场规模和预测是多少？

2.在抗菌素抗药性监测市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3. 抗菌药物抗药性监测市场的技术趋势和法规结构是什么？

4.抗菌药物抗药性监测市场主要供应商的市场占有率是多少？

5. 进入抗菌药物抗药性监测市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 病原体引起的感染疾病传播增加
      • 政府加强提高诊断和照护现场质量
    • 抑制因素
      • 与抗菌药物抗药性监测相关的高成本
    • 机会
      • 对管理抗菌素抗药性 (AMR)感染疾病的先进诊断解决方案的需求不断增长
      • 全球诊断产品的监管核准增加
    • 任务
      • 缺乏抗菌素抗药性监测的标准化方法和指南
  • 市场区隔分析
    • 组件：诊断套件在以相对较低的成本快速检测特异性抗性标记物方面发挥重要作用
    • 最终用户：医院感染发生率的增加推动了对下一代抗菌素抗药性 (AMR) 监测的需求。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章抗菌药物抗药性监测市场：依组成部分

  • 诊断套件
  • 诊断系统
  • 服务
  • 软体

第七章 抗菌药物抗药性监测市场：依最终用户分类

  • 医院
  • 研究/学术机构

第八章美洲抗菌药物抗药性监测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区抗菌药物抗药性监测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲抗菌药物抗药性监测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Novo Holdings 透过收购 Paratech Pharmaceuticals 推动抗菌素抗药性策略
    • AMR行动基金宣布进一步投资对抗抗生素抗药性
  • 战略分析和建议

第十二章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-CF6C60CF95A8

[196 Pages Report] The Antimicrobial Resistance Surveillance Market size was estimated at USD 5.60 billion in 2023 and expected to reach USD 5.96 billion in 2024, at a CAGR 6.49% to reach USD 8.71 billion by 2030.

The antimicrobial resistance surveillance market encompasses products to monitor, analyze, and control the spread of microorganisms that develop resistance to antibiotics, antivirals, antifungals, and other antimicrobial agents. The primary application of antimicrobial resistance surveillance is to provide information on the prevalence of resistant pathogens in various settings such as hospitals, community health centers, food production facilities, animal husbandry operations, water treatment plants, and environmental samples. The increasing prevalence of multidrug-resistant organisms worldwide necessitates constant monitoring to adapt existing treatments appropriately. Advances in molecular diagnostics techniques enable early detection and identification of antibiotic-resistant strains. Addtionally, growing awareness about antibiotic stewardship programs among healthcare professionals encourages prudent prescribing practices. Despite the growth prospects, several challenges hinder the antimicrobial resistance surveillance market progress. Inadequate infrastructure and funding in low and middle-income countries result in limited surveillance capabilities. Variability in laboratory methodologies employed worldwide hampers comparability of results across regions. However, the emergence of point-of-care testing devices expedites diagnosis and enables personalized treatment decisions. Harnessing genomic sequencing technologies allows for accurate tracking of resistance mechanisms and transmission dynamics at a population level. Along with these, to sustain business growth and contribute to global health security, stakeholders should focus on key areas like refining diagnostic tools for faster detection, exploring unconventional treatment approaches, utilizing artificial intelligence for predictive modeling.

KEY MARKET STATISTICS
Base Year [2023] USD 5.60 billion
Estimated Year [2024] USD 5.96 billion
Forecast Year [2030] USD 8.71 billion
CAGR (%) 6.49%

Component: Significant role of diagnostic kits in offering rapid detection of specific resistance markers at relatively lower costs

The antimicrobial resistance (AMR) surveillance market comprises various components that help identify and manage drug-resistant pathogens. Diagnostic kits are essential for accurate and rapid detection of antimicrobial resistance in pathogens, enabling timely intervention with appropriate antibiotic therapy. These kits employ various techniques such as polymerase chain reaction (PCR), enzyme-linked immunosorbent assays (ELISA), and next-generation sequencing (NGS) to identify resistant genes in microorganisms. Diagnostic systems encompass laboratory-based instruments that facilitate high-throughput screening and advanced data analysis for AMR detection. AMR surveillance services include contract research organizations (CROs) and laboratories that provide accelerated susceptibility testing, whole-genome sequencing, and bioinformatics analysis. These services enable healthcare providers to access cutting-edge technology and expertise for detecting resistant pathogens without investing in expensive equipment or specialists. Data management software plays a crucial role in compiling, analyzing, and interpreting the vast amount of information generated during AMR surveillance.

End-User: Increasing incidence of hospital-acquired infections developed necessities for next generation antimicrobial resistance (AMR) surveillance

In the fight against antimicrobial resistance (AMR), hospitals and research & academic institutes play critical roles, necessitating tailored surveillance systems to address their distinct needs. Hospitals prioritize rapid diagnostic solutions that guide clinicians in providing appropriate antibiotic treatments and preventing the spread of resistant infections. Research & academic institutes focus on understanding antimicrobial resistance mechanisms, developing novel therapeutic approaches, and promoting responsible antibiotic use among healthcare professionals.

Regional Insights

Antimicrobial resistance (AMR) has emerged as a significant public health threat across the Americas and Europe. Continuous surveillance of AMR is crucial in understanding the growing impact on healthcare systems, guiding policy decisions, and implementing effective strategies to mitigate the risks associated with resistant infections. The major driving factors behind increased AMR levels in the Americas and Europe include the overuse and misuse of antimicrobials in human medicine, veterinary practice, agriculture, and food production sectors. In developed countries across the Americas and Europe, stringent regulatory frameworks govern the actions of manufacturers and providers of antimicrobial products. The potential associated with emerging countries in addressing AMR is immense due to factors such as rapid economic growth, increasing healthcare expenditure, and favorable government policies. Emerging economies like India, China, and Brazil are investing heavily in R&D for antimicrobial resistance surveillance and promoting public-private partnerships to address the issue. Governments provide financial support for research and development (R&D) efforts to incentivize innovation in addressing antimicrobial resistance. For instance, in August 2023, the UK government made a significant investment of £210 million to enhance global surveillance of drug-resistant bacteria, a critical aspect of Antimicrobial Resistance (AMR) surveillance. However, initiatives focusing on surveillance systems enhancement, regulatory oversight improvements, investment in research, and development of new treatments are crucial to combating this threat effectively.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antimicrobial Resistance Surveillance Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antimicrobial Resistance Surveillance Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Resistance Surveillance Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company, bioMerieux SA, Cepheid, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Liofilchem S.r.l., Lumed, Luminex Corporation, Merck & Co., Inc., Novo Holdings A/S, OpGen, Inc., Pfizer Inc., QIAGEN GmbH, Sanofi S.A., Thermo Fisher Scientific Inc., Venatorx Pharmaceuticals, Inc., Viatris Inc., Vivli Inc., and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Resistance Surveillance Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Diagnostic Kits
    • Diagnostic Systems
    • Services
    • Software
  • End-User
    • Hospitals
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antimicrobial Resistance Surveillance Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antimicrobial Resistance Surveillance Market?

3. What are the technology trends and regulatory frameworks in the Antimicrobial Resistance Surveillance Market?

4. What is the market share of the leading vendors in the Antimicrobial Resistance Surveillance Market?

5. Which modes and strategic moves are suitable for entering the Antimicrobial Resistance Surveillance Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infections caused by pathogens
      • 5.1.1.2. Rising government initiatives to improve the quality of diagnostics and point-of-care diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with antimicrobial resistance surveillance
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for advanced diagnostic solutions to manage Antimicrobial Resistance (AMR) infections
      • 5.1.3.2. Increasing regulatory approvals of diagnostics products worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized methods and guidelines for AMR surveillance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Significant role of diagnostic kits in offering rapid detection of specific resistance markers at relatively lower costs
    • 5.2.2. End-User: Increasing incidence of hospital-acquired infections developed necessities for next generation antimicrobial resistance (AMR) surveillance
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Antimicrobial Resistance Surveillance Market, by Component

  • 6.1. Introduction
  • 6.2. Diagnostic Kits
  • 6.3. Diagnostic Systems
  • 6.4. Services
  • 6.5. Software

7. Antimicrobial Resistance Surveillance Market, by End-User

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Research & Academic Institutes

8. Americas Antimicrobial Resistance Surveillance Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antimicrobial Resistance Surveillance Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antimicrobial Resistance Surveillance Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Novo Holdings advances antimicrobial resistance strategy with acquisition of Paratek Pharmaceuticals
    • 11.3.2. AMR Action Fund announces more investments to combat antibiotic resistance
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET DYNAMICS
  • FIGURE 7. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 30. ARGENTINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. ARGENTINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. BRAZIL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 34. BRAZIL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 35. BRAZIL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. BRAZIL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. CANADA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 38. CANADA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 39. CANADA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. CANADA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. MEXICO ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 42. MEXICO ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 43. MEXICO ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. MEXICO ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 50. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 58. AUSTRALIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AUSTRALIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. CHINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 62. CHINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 63. CHINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. CHINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. INDIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 66. INDIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 67. INDIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. INDIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. INDONESIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 70. INDONESIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 71. INDONESIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. INDONESIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. JAPAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 74. JAPAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 75. JAPAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. JAPAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 78. MALAYSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. MALAYSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 82. PHILIPPINES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. PHILIPPINES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 86. SINGAPORE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. SINGAPORE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 90. SOUTH KOREA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. SOUTH KOREA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. TAIWAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 94. TAIWAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 95. TAIWAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. TAIWAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. THAILAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 98. THAILAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 99. THAILAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. THAILAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. VIETNAM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 102. VIETNAM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 103. VIETNAM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. VIETNAM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. DENMARK ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 112. DENMARK ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 113. DENMARK ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. DENMARK ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. EGYPT ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 116. EGYPT ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 117. EGYPT ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. EGYPT ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. FINLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 120. FINLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 121. FINLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. FINLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. FRANCE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 124. FRANCE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 125. FRANCE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. FRANCE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. GERMANY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 128. GERMANY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 129. GERMANY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. GERMANY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. ISRAEL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 132. ISRAEL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 133. ISRAEL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. ISRAEL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. ITALY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 136. ITALY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 137. ITALY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. ITALY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 140. NETHERLANDS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. NETHERLANDS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. NIGERIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 144. NIGERIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 145. NIGERIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. NIGERIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. NORWAY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 148. NORWAY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 149. NORWAY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. NORWAY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. POLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 152. POLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 153. POLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. POLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. QATAR ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. QATAR ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. QATAR ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. QATAR ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. RUSSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 160. RUSSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 161. RUSSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. RUSSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. SAUDI ARABIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. SPAIN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 172. SPAIN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 173. SPAIN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. SPAIN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. SWEDEN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 176. SWEDEN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 177. SWEDEN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. SWEDEN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 180. SWITZERLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. SWITZERLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. TURKEY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 184. TURKEY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 185. TURKEY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. TURKEY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, FPNV POSITIONING MATRIX, 2023